Gina Μ. Michels

Zoetis (United States) — United States

Medicine · Health Sciences

11h-index1.2kcitations27works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Veterinary Oncology Research(11), Infectious Diseases and Mycology(10), Mast cells and histamine(6), Veterinary Orthopedics and Neurology(3), Asthma and respiratory diseases(2)

Publications27 total

A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody
Veterinary Anaesthesia and Analgesia·2023· 23 citedOpen Access
CCR Translation for the Article from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
Supplementary Data from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
Data from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
Supplementary Data from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
CCR Translation for the Article from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
Data from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
Linguistic Validation of the Canine Brief Pain Inventory (CBPI) for Global Use
Frontiers in Veterinary Science·2021· 11 citedOpen Access
A blinded, randomized, placebo‐controlled trial of the safety of lokivetmab (<scp>ZTS</scp>‐00103289), a caninized anti‐canine <scp>IL</scp>‐31 monoclonal antibody in client‐owned dogs with atopic dermatitis
Veterinary Dermatology·2016· 45 citedOpen Access
A blinded, randomized, placebo‐controlled, dose determination trial of lokivetmab (<scp>ZTS</scp>‐00103289), a caninized, anti‐canine <scp>IL</scp>‐31 monoclonal antibody in client owned dogs with atopic dermatitis
Veterinary Dermatology·2016· 88 citedOpen Access
Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: a review
Journal of Veterinary Pharmacology and Therapeutics·2014· 28 cited
Technische Mitteilung: Fehlplatzierter 13F-Shaldonkatheter in der A. subclavia – kontrollierte Entfernung mit einem unterdimensionierten 8F-Kollagen-Verschlusssystem (AngioSeal®) und endovaskulärer Ballonfixation
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren·2011· 4 cited
Komplikation nach perkutaner Dilatationstracheotomie
DMW - Deutsche Medizinische Wochenschrift·2011
Pharmacokinetic properties of toceranib phosphate (Palladia™, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors
Journal of Veterinary Pharmacology and Therapeutics·2010· 42 cited
„Systemic inflammatory response syndrome“ (SIRS), Sepsis und septischer Schock
2010
Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a veterinary cooperative oncology group (VCOG) consensus document
Veterinary and Comparative Oncology·2009· 274 cited
Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
Clinical Cancer Research·2009· 416 citedOpen Access
PHARMACOKINETICS AND PHARMACODYNAMICS OF MAVACOXIB IN THE DOG
RVC Research Online (Royal Veterinary College)·2009· 4 citedOpen Access
Prognosis Following Surgical Excision of Canine Cutaneous Mast Cell Tumors With Histopathologically Tumor-Free Versus Nontumor-Free Margins: A Retrospective Study of 31 Cases
Journal of the American Animal Hospital Association·2002· 113 cited
Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats
Journal of the American Veterinary Medical Association·2001· 35 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Cheryl A. London(8), Joseph F. Boucher(8), Phyllis B. Malpas(7), Stacey L. Wood-Follis(7), Anthony Rusk(7), Mona P. Rosenberg(7), Carolyn J. Henry(7), Kathy L. Mitchener(7), Mary K. Klein(7), John G. Hintermeister(7), Philip J. Bergman(7), Guillermo Couto(7), G. Neal Mauldin(7), Rodney R. Walters(3), Kelly F. Walsh(2), Olivier M. Martinon(2), Sean P. Mahabir(2), Jacquelien Hoevers(2), Brent D. Jones(2), Colette Wagner‐Mann(2)